POSTER SESSION IV
Tuesday, March 10, 2009 — 1:00 PM - 4:30 PM
Hynes CC Exhibit Hall C/D
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
BREAST PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
1
A New Approach to Breast Carcinoma Detection: NYBR-1 Teamed up with Mammaglobin and Gross Cystic Disease Fluid Proteins
(234)
H Liu, S Muralitharan - Thermo Fisher Scientific (Anatomical Pathology Division), Fremont, CA
Breast Carcinoma of Combined Histologic Grade 2: Prognostic Significance of Immunohistochemical Features
(228)
J Laforga, F Ignacio Aranda, M Niveiro, T Muci, J Segui, A Paya, G Peiro - Hospital of Denia, Denia, Alicante, Spain; Universitary General Hospital, Alicante, Spain
Mucocele-Like Lesions of Breast with No or Minimal Epithelial Atypia on Core Biopsy: To Excise or Not?
(258)
CV Nguyen, E Resetkova, L Huo - University of Texas M.D. Anderson Cancer Center, Houston, TX
Estrogen Receptor Expression in Atypical Hyperplasia and Its Association with Type of Atypia and Age
(118)
EG Barr-Fritcher, LC Hartmann, AC Degnim, SS Anderson, RA Vierkant, M Frost, DW Visscher, C Reynolds - Mayo Clinic, Rochester, MN; University of Michigan, Ann Arbor, MI
Histologic Grading of Invasive Lobular Carcinoma: Does Use of a Two-Tiered Nuclear Grading System Improve Interobserver Variability?
(104)
AL Adams, DC Chhieng, WC Bell, T Winokur, O Hameed - University of Alabama at Birmingham, Birmingham, AL
Interval Breast Cancers Are Associated with More Aggressive Pathologic Characteristics Compared to Screen-Detected Cancers: A Nested Case Control Study from a Canadian Breast Screening Program
(275)
D Rayson, JI Payne, PJ Barnes, RF MacIntosh, M Abdolell, T Foley, AM Burns, T Younis, JS Caines - Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada; Cancer Care Nova Scotia, Halifax, NS, Canada; Dalhousie University, Halifax, NS, Canada; Nova Scotia Breast Screening Program, Halifax, NS, Canada
Acidophilic Nuclear Inclusions Are Fairly Specific for Florid Duct Hyperplasia among Proliferative Breast Lesions
(229)
S Lauer, G Oprea, A Adams, C Cohen, NV Adsay - Emory University Hospital, Atlanta, GA; Grady Memorial Hospital, Atlanta, GA
Significance of Radial Scar Diagnosis in Breast Core Biopsy and Correlation with Follow up Surgical Excision
(209)
A Kanbour-Shakir, YC Teh, M Bonaventura, A Soran - Magee-Womens Hospital of UPMC Health System, Pittsburgh, PA
Evaluation of Lymphatic Involvement within Needle Biopsy for Breast Carcinoma. Is It Useful?
(242)
M Masako, T Uematsu, K Nagata - Shizuoka Cancer Center Hospital and Research Institute, Nagaizumi, Shizuoka, Japan
Neovascularization in Mucinous Ductal Carcinoma In Situ Suggests an Alternative Pathway for Invasion
(169)
SA Gadre, GH Perkins, AA Sahin, N Sneige, MT Deavers, LP Middleton - The University of Texas M. D. Anderson Cancer Center, Houston, TX
Papillary Carcinoma of the Breast Lacks Evidence of RET Rearrangements Despite Morphological Similarities to Papillary Thyroid Carcinoma
(190)
O Hameed, A Perry, H Banerjee, X Zhu, JA Pfeifer - University of Alabama School of Medicine, Birmingham; Washington University School of Medicine, St. Louis, MO
Outcome of Papillary Carcinoma of Breast, One Institutional Experience
(146)
C Cookingham, X Jing, D Vishcher - University of Michigan Health Syatem, Ann Arbor, MI
Is the Histologic Tumor Grade an Important Prognostic Factor in Small (T1, T2) Node-Negative Breast Adenocarcinomas?
(274)
MS Purdom, ML Cibull, LM Samayoa, TD Stratton, EH Romond, PC McGrath, RG Karabakhtsian - University of Kentucky, Lexington, KY
Analysis of CD34, CD117, and Ki-67 Expression in 33 Cases of Phyllodes Tumor of the Breast
(263)
YS Noronha, AS Raza, DR Chase, CA Garberoglio, P Chu, LM Weiss, J Wang - Loma Linda University Medical Center, Loma Linda, CA; City of Hope National Medical Center, Duarte, CA
Increased Lymphatic Vessel Density in Positive Sentinel Lymph Nodes Predicts Additional Nodal Disease in Breast Cancer
(176)
M Ghayouri, MJ Wagoner, J Kiluk, C Laronga, CE Cox, G Acs - Moffitt Cancer Center, Tampa, FL; University of South Florida College of Medicine, Tampa, FL
Invasive Ductal Carcinoma with Lobular Features and Invasive Pleomorphic Lobular Carcinoma - Are They Different Entities?
(267)
G Omeroglu, WM Hanna, S Nofech-Mozes - Sunnybrook Health Sciences Centre, Toronto, Canada
Angiosarcoma of the Breast: A Rare Complication of Radiation Therapy. Clinicopathologic Study of 33 Cases in a Single Institution
(247)
EA Morgan, CM Mery, DE Kozono, JE Butrynski, EH Baldini, CP Raut, AF Nascimento - Brigham and Women's Hospital, Boston, MA; BWH and Dana-Farber Cancer Institute, Boston; DFCI, Boston; BWH, Boston, MA
Mitotic Index of Breast Carcinoma: Understanding and Remedying Irreproducibility
(245)
JS Meyer, E Cosatto, HP Graf - St. Luke's Hospital, Chesterfield, MO; NEC Laboratories, Princeton, NJ
Expression of Cartilage-Specific Markers in Matrix-Producing Carcinoma of the Breast
(145)
A Contreras, T Krausz, A Montag, M Tretiakova, R Wilcox, K Gwin - The University of Chicago Medical Center, Chicago, IL
The Incidence of Concurrent Lobular Carcinoma In Situ, Columnar Cell Lesions and Tubular Carcinoma: An Analysis of 105 Cases
(108)
I Alvarado-Cabrero, ME Rojas-Torres, V Rubio - Mexican Oncology Hospital, Mexico, DF, Mexico
The Effect of Withdrawal of Combined Hormone Replacement Therapy on the Proliferation of Breast Cancers in Postmenopausal Women
(243)
R Mathew, C Laronga, G Acs - University of South Florida College of Medicine, Tampa, FL; Moffitt Cancer Center, Tampa, FL
Multiple Pathological Factors Contribute to Diagnostic Uncertainty in Mammary Low-Grade Adenosquamous Carcinoma. A Review of 35 Consultation Cases
(329)
GQ Young, SM Brandt, SA Hoda - Weill Cornell Medical College, New York, NY
Immunoexpression of Fli-1 by Metaplastic Breast Cancer: A Potential Pitfall in Cases Morphologically Resembling Epithelioid Angiosarcoma
(177)
RM Gill, EF Brachtel, AE Horvai, YY Chen, JT Rabban - UCSF, San Francisco, CA; Massachusetts General Hospital, Boston, MA
Clinical Analysis of Mucocele-Like Tumors of the Breast: Analysis of a Large Benign Breast Disease Cohort
(316)
DW Visscher, R Vierkant, M Frost, C Reynolds, S Anderson, L Hartmann - University of Michigan, Ann Arbor, MI; Mayo Clinic, Rochester, MN
Anaplastic Large Cell Lymphoma Arising in Association with Breast Implants and Mimicking Recurrent Breast Carcinoma: A Report of Five Cases
(153)
M De Peralta-Venturina, RN Miranda, LJ Medeiros, G Gualco, CE Bacchi, M Amin - William Beaumont Hospital, Royal Oak, MI; University of Texas, M.D. Anderson Cancer Center, Houston, TX; Consultoria em Patologica, Botucatu, Sao Paulo, Brazil
Grap2 and Cyclin-D Interacting Protein Nuclear Expression Is Significantly More Frequent in Triple-Negative Breast Carcinomas than Other Subtypes of Breast Carcinomas
(135)
WC Chen, MC Chang, TW Chang - National Cheng Kung University Medical Center, Tainan, Taiwan
Fhit, Wwox and AP2 g Expression Levels Correlate with Basal Phenotype in Breast Cancer
(186)
G Guler, K Huebner, CH Ussakli, R Jimenez, S Constinean, S Volinia, RT Pilarski, M Hayran, CL Shapiro - Hacettepe University, Ankara, Turkey; The Ohio State University, Columbus, OH; Institute of Oncology Hacettepe University, Ankara, Turkey
Basal-Like Breast Carcinoma: Identifying Estrogen Receptor Positive Cases
(180)
DC Gingell, S O'Connor, R Bhargava, DJ Dabbs - Magee-Womens Hospital of UPMC, Pittsburgh, PA
Basal-Like Breast Cancer Displays Distinct Promoter Methylation Profiles
(219)
SS Kim, CW Han, JS Lee, JH Lee, JH Nam, C Choi, MJ Fackler, S Sukumar - Chonnam National University Medical School, Gwangju, Republic of Korea; Johns Hopkins University School of Medicine, Baltimore, MD
Expression of Gamma-Laminin, Cytokeratin 5 and Cytokeratin 5/6 in Metaplastic and Basal-like Breast Carcinomas
(264)
SM O'Connor, L Niemeier, R Bhargava, WT Parks, DJ Dabbs - UPMC Magee-Womens Hospital, Pittsburgh, PA
Histopathologic and Staging Characteristics of ER/PR/HER2 "Triple-Positive" Mammary Carcinoma
(202)
G Ibrahim, S White, SG Karak, A Ricci, Jr - Hartford Hospital, Hartford, CT
Identification of Cancer-Specific Glycoproteins in Triple-Negative Breast Cancer
(313)
LH Tseng, P Argani, Y Li, Y Tian, MF Lopez, D Sarracino, T Rezai, M Athanas, B Krastins, DW Chan, H Zhang - Johns Hopkins Medical Institutions, Baltimore; Thermo Fisher Scientific, Cambridge, MA; VAST Scientific, Cambridge, MA
Diagnostic Utility of SNAIL in Metaplastic Breast Carcinoma
(252)
A Nassar, TA Giorgadze, C Cohen - Mayo Clinic, Rochester, MN; Wayne State University, Detroit, MI; Emory University Hospital, Atlanta, GA
Spindle Cell (Sarcomatous) Carcinoma of the Breast: Immunohistochemical Profile and the Clinical Outcome
(207)
S Johnykutty, D Hicks, K Skinner, C Andrus, L Schiffhauer, M Worman, X Wang - U of Rochester, Rochester, NY
Clinicopathologic Characteristics in Correlation with Protein Expression Profile in Triple Negative Breast Cancer in Our Population
(131)
R Busch, C Cohen, SE Pambuccian, R Gamez, R O'Regan, L Yang, HE Gulbahce, GM Oprea-Ilies - Emory University, Atlanta, GA; University of Minnesota, Minneapolis, MN
Breast Cancer Molecular Class ERBB2: Preponderance of Tumors with Apocrine Differentiation and Expression of Basal Phenotype Markers CK5, CK5/6 and EGFR
(122)
R Bhargava, JM Striebel, DJ Dabbs - Magee-Womens Hospital of UPMC, Pittsburgh, PA
Tissue Microarray - Based IHC Study Can Significantly Underestimate the Expression of HER2
(195)
J Hatem, Y Lin, JM Wang, DG Hicks, P Tang - University of Rochester Medical Center, Rochester, NY; RTI Health Solution, Research Triangle Park, NC
Expression of Sox9 Is Significantly Associated with Basal-Like Phenotype in Invasive Mammary Carcinoma
(237)
S Lu, A Mercurio, M Prasad, A Khan - University of Massachusetts Medical School, and UMassMemorial Medical Center, Worcester, MA
Influence of Cytokeratin 5/6, EGFR, p53 and Ki-67 Index on Pathologic Complete Response Rate to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancers: Preliminary Results from the I-SPY TRIAL (CALGB 150007/150012 and ACRIN 6657)
(235)
CA Livasy, LA Carey, A DiMichelle, K Conway, D Cowan, D Little, J Markey, DT Moore, L Dressler, I-SPY Clinical Investigators - Univ of North Carolina, Chapel Hill, NC; Univ of Pennsylvania, Philadelphia, PA; I-SPY Trial Network
Metaplastic Breast Carcinomas Are Basal-Like Breast Cancers: A Genomic Profiling Analysis
(322)
B Weigelt, B Kreike, JS Reis-Filho - Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley; The Netherlands Cancer Institute, Amsterdam, Netherlands; ICR, London, United Kingdom
CXCL10 Tumor Expression in BRCA1 and Non-BRCA1-Associated Breast Cancer
(248)
AM Mulligan, I Raitman, D Pinnaduwage, FP O'Malley, IL Andrulis - St. Michae's Hospital, Toronto, ON, Canada; Samuel Lunenfeld Research Institute, Toronto, ON, Canada; Mount Sinai Hospital, Toronto, ON, Canada
button next to any title to add to Itinerary Planner...
Add
